In Blow To Teva, Federal Circuit Refuses To Rehear Zoloft Patent Case
The U.S. Court of Appeals for the Federal Circuit has refused Israeli drug maker Teva Pharmaceuticals' request for an en-banc rehearing of its patent case over a generic version of Pfizer...To view the full article, register now.
Already a subscriber? Click here to view full article